drugset / Trial / NCT01860066
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
RandomizedParallel-groupDouble-blindTreatment
Summary
Study is to show that QVA149 is superior to the standard of care, fluticasone/salmeterol, in patients with moderate to severe airflow limitation.
Timeline
- Start
- 2013-12
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone | Other / unclassified | — | Inhaled |
| Subject | QVA149 | Other / unclassified | — | Inhaled |
| Comparator | Salmeterol | Other / unclassified | — | Inhaled |